Products for Research Use Only
RegisterLogin

Erufosine

CAT: 0931-T211021-01Size: 10 mgDry Ice: NoHazardous: No
Product image 1
1 / 1
CAT#:0931-T211021-01Size:10 mg
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
CAS Number
202867-33-2
Target
Raf, Ras, Akt, p38 MAPK, PI3K
Related Pathways
PI3K/Akt/mTOR signaling, MAPK, Cytoskeletal Signaling
Bioactivity
Erufosine is an inhibitor of the PI3K/Akt and Ras/Raf/MAPK signaling pathways. It suppresses the activity of breast cancer cell lines MCF-7 and MDA-MB 231 with an IC50 of 40.95/40.8 μM, respectively. Erufosine reduces phosphorylation of PI3K (p85), Akt (PKB), and cRaf, making it applicable in research on breast cancer and myeloid leukemia.
Smiles
P(OCCCCCCCCCCCC/C=C\CCCCCCCC)(OCCC[N+](C)(C)C)(=O)[O-]
Molecular Formula
C28H58NO4P
Molecular Weight
503.74
Shipping Conditions
Ice Packs
Storage Temperature
-20°C

Alternative Products

CatalogName
HY-171777Erufosine

Popular Products